This “insight” is regarding technical analysis versus what the company may offer regarding drugs. Yes INCY is a drug maker. The more interesting aspect is the sector in general. The sector has been under fire with the government pushing to stop price gouging. With drug pricing reaching insane levels, the drugmakers took a big hit over the last year. Not all names are affected but INCY was a name that struggled for gains while the rest of the market rallied. This year it is a different story with INCY. The stock rallied back since the start of the year and has been going back and forth in recent trading sessions. Now I normally HATE chart patterns, but hard to ignore this one. With the stock starting to “Flag” or “Pennant”, we could be finding a huge breakout opportunity in either direction. Basically, it depends on which way INCY breaks. Breaking resistance or support. The support is the ascending trendline higher, and resistance is the descending trend line. If you see my illustration, it is hard to ignore the red lines. Now, I am not touching INCY until a break-out occurs. Once it does, expect a big trending move to take place. INCY HAS to be on your watchlist for the near term.

Follow me on Twitter: @DiscipleOfTrend

about the author:

Charles Moon

Charles Moon is a technical "whiz kid" whose experience lies in scalp/swing trading. A patient educator, Charles excels at coaching/mentoring and can make complex concepts simple. Prior to joining the ranks of Prosper Trading Academy, Charles was a proprietary equities trader with Great Point Capital LLC. Coming from a retail trading background, his experience can help those with no experience trading to seasoned veterans.

Read Similar Articles

July 25, 2026

The Week Ahead: STOP SPENDING!

Renewed geopolitical risk, rising oil prices, and disappointing reactions to mega-cap earnings gave investors plenty to digest this week. The two biggest market headlines this week were GOOGL’s capex spending and renewed escalation in the Middle East.  More on the GOOGL spending below. Brent crude traded above $100 per barrel, while the U.S. benchmark, West […]

Read Article
https://www.prospertrading.com/bauer-intc-schwab-072426/Intel Had a Great Report. Scott Bauer Is Buying the Dip.
July 24, 2026

Intel Had a Great Report. Scott Bauer Is Buying the Dip.

Intel posted a strong earnings report this morning and the stock is selling off anyway. Scott Bauer joined Schwab Network today to explain why he thinks the market is getting this one wrong and how he is positioning around it.

Read Article
https://www.prospertrading.com/moon-big-3-072326/The Big 3 with Charlie Moon: : GOOGL, SKHY, and IREN
July 23, 2026

The Big 3 with Charlie Moon: : GOOGL, SKHY, and IREN

Charlie Moon joined Schwab Network’s Big 3 segment to break down three trades across some of the most active names in the AI buildout right now. Here’s his read on the market and exactly how he’s positioning.

Read Article

Read Similar Articles

July 15, 2026

The Fed, Oil, and What Earnings Season Really Means

Scott Bauer joined the IBKR Podcast this week to break down what moved markets last week and what investors need to watch heading into the next stretch of earnings season. From lagging inflation data to big tech CapEx concerns, Scott did not hold back.

Read Article
July 5, 2026

The Week Ahead: Happy 250

The Dow rose more than ​1% to a record closing high on Thursday ahead of the long holiday weekend as a softer-than-expected U.S. ‌jobs report eased worries about interest rate hikes, while another sharp drop in chipmaker stocks weighed on the Nasdaq. The second half of 2026 kicked off this week much the same as […]

Read Article
June 28, 2026

The Week Ahead: Darn Inflation

A renewed sell-off in technology stocks grabbed headlines this week. The Nasdaq index fell 4.5%, closing lower 5 days in a row, led by a large 5.5% decline in the so-called Magnificent 7 mega cap names. Meanwhile, the post IPO exuberance around SpaceX appears to be fading, with shares now down 25% from their peak. […]

Read Article